Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipid-lowering interventions in angiographic trials

J E Rossouw1

  • 1Office of Disease Prevention, National Institutes of Health, Bethesda, Maryland 20982, USA.

The American Journal of Cardiology
|September 28, 1995
PubMed
Summary

Lowering cholesterol effectively reduces coronary artery disease progression and cardiovascular events. Lipid-lowering interventions, including lifestyle changes, drugs, and surgery, demonstrate favorable angiographic and clinical outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reliable evidence from placebo-controlled, randomized, clinical trials for menopausal hormone therapy's influence on incidence and deaths from breast cancer.

Climacteric : the journal of the International Menopause Society·2015
Same author

Incidence of milk alkali syndrome in the Women's Health Initiative clinical trial and cohort study: response to Neupane.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2013
Same author

Calcium supplements and cardiovascular risk in the Women's Health Initiative: response to Bolland et al.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2013
Same author

Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2012
Same author

Cognitive function and retinal and ischemic brain changes: the Women's Health Initiative.

Neurology·2012
Same author

Postmenopausal hormone therapy for disease prevention: have we learned any lessons from the past?

Clinical pharmacology and therapeutics·2008

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Lipidology

Background:

  • Coronary artery disease (CAD) remains a leading cause of mortality worldwide.
  • Effective lipid-lowering strategies are crucial for managing CAD.
  • Previous studies have evaluated various cholesterol-lowering interventions with mixed results on angiographic and clinical outcomes.

Purpose of the Study:

  • To perform a meta-analysis of pooled data from randomized angiographic trials on cholesterol-lowering interventions.
  • To evaluate the impact of different lipid-lowering interventions on coronary artery disease progression, regression, and cardiovascular events.
  • To determine the efficacy of lipid reduction in modifying angiographic outcomes and reducing clinical events.

Main Methods:

  • Pooled analysis of data from 14 published randomized angiographic trials (16 treatment arms).

Related Experiment Videos

  • Meta-analysis of angiographic outcomes including disease progression, no change, and regression.
  • Assessment of cardiovascular event rates across different cholesterol-lowering interventions.
  • Stratification of analyses by intervention type (lifestyle, drugs, surgery) and baseline LDL levels.

    • Main Results:

    • All interventions significantly reduced low-density lipoprotein (LDL) cholesterol by an average of 26%.
    • Lipid reduction treatments decreased odds of disease progression by 49% and increased odds of regression by 219%.
    • Cardiovascular events were reduced by 47%; surgery showed the most favorable angiographic outcome.

    Conclusions:

    • Lipid reduction is effective in modifying angiographic outcomes and reducing coronary artery disease events.
    • All evaluated interventions (lifestyle, drugs, surgery) yielded favorable angiographic and clinical results.
    • Lowering LDL cholesterol by approximately 30 mg/dl is hypothesized to be sufficient for significant angiographic modification.